Stereotaxis Announces Completion of Clinical Trial of Vdrive with V-Loop System

By: Benzinga
Stereotaxis (Nasdaq: STXS ) announced today that it has completed the clinical trial required for FDA clearance of the Company's Vdrive Robotic Navigation System with V-Loop Circular Catheter Manipulator. Results of the 120-patient study, which was conducted at three Stereotaxis sites in the U.S. and two in Europe, will
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.